Vincent Verschaeve

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois et al. · Annals of Oncology · 2012 · 124 citations · Full text

Medicine, Oncology, Pharmacology +14

Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer

Jean‐Pascal Machiels, F Mazzeo, Marylène Clausse et al. · Journal of Clinical Oncology · 2008 · 87 citations · Full text

Medicine, Oncology, Pharmacology +15

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

Johnny Duerinck, Stephanie Du Four, Frank Bouttens et al. · Journal of Neuro-Oncology · 2017 · 63 citations

Medicine, Oncology, Pharmacology +13

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium

Cindy Kenis, Lore Decoster, Johan Flamaing et al. · Annals of Oncology · 2018 · 61 citations · Full text

Medicine, Geriatric Medicine, Oncology +16